HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joseph E Ippolito Selected Research
Joseph E Ippolito Research Topics
Disease
18
Neoplasms (Cancer)
06/2022 - 03/2004
10
Prostatic Neoplasms (Prostate Cancer)
07/2022 - 01/2014
2
Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2017
2
Glioma (Gliomas)
01/2021 - 08/2017
2
Mouth Neoplasms (Oral Cancer)
11/2019 - 10/2019
2
Neoplasm Metastasis (Metastasis)
01/2019 - 11/2002
2
Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 01/2014
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022
1
Migraine Disorders (Migraine)
12/2020
1
Migraine with Aura (Familial Hemiplegic Migraine)
12/2020
1
Paralysis (Palsy)
12/2020
1
Lymphadenopathy
11/2017
1
Ovarian Neoplasms (Ovarian Cancer)
11/2017
1
Peritoneal Diseases
11/2017
1
Disease Progression
11/2017
1
DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2017
1
Flushing
07/2016
1
Carcinogenesis
07/2014
1
Pancreatic Neoplasms (Pancreatic Cancer)
07/2014
1
Neuroendocrine Carcinoma
01/2014
1
Adenocarcinoma
01/2014
1
Stomach Neoplasms (Stomach Cancer)
03/2004
Drug/Important Bio-Agent (IBA)
5
Biomarkers (Surrogate Marker)
IBA
06/2022 - 11/2002
3
Glucose (Dextrose)
FDA Link
Generic
06/2022 - 01/2018
3
Acids
IBA
01/2019 - 03/2004
3
Enzymes
IBA
07/2014 - 08/2006
3
gamma-Aminobutyric Acid (GABA)
IBA
01/2014 - 07/2005
2
Biological Products
IBA
01/2021 - 07/2016
2
Pyruvic Acid (Pyruvate)
IBA
10/2019 - 08/2017
2
Androgens
IBA
01/2019 - 01/2014
2
Calcium Carbonate (Limestone)
FDA Link
01/2019 - 07/2016
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2018 - 01/2017
2
Neurotransmitter Agents (Neurotransmitter)
IBA
01/2014 - 01/2006
2
Amiloride (Midamor)
FDA Link
Generic
08/2006 - 07/2005
2
Dopa Decarboxylase
IBA
08/2006 - 07/2005
2
GABA-A Receptors (GABA(A) Receptor)
IBA
08/2006 - 07/2005
1
FR900359
IBA
01/2022
1
Polysaccharides (Glycans)
IBA
01/2021
1
Adenosine Triphosphatases (ATPase)
IBA
12/2020
1
Ion Pumps (Ion Pump)
IBA
12/2020
1
Lactic Acid (Lactate)
FDA Link
Generic
10/2019
1
Proteins (Proteins, Gene)
FDA Link
10/2019
1
Carcinogens
IBA
10/2019
1
Lipids
IBA
10/2019
1
Messenger RNA (mRNA)
IBA
10/2019
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2019
1
Ferrosoferric Oxide (Magnetite)
FDA Link
01/2019
1
Therapeutic Uses
IBA
01/2019
1
Antigens
IBA
01/2018
1
Choline (Choline Chloride)
IBA
01/2018
1
thiamine triphosphorate (TTP)
IBA
11/2017
1
Proton Pump Inhibitors
IBA
07/2016
1
Niclosamide
FDA Link
01/2016
1
Transcription Factor 4
IBA
01/2016
1
Adenosine Triphosphate (ATP)
IBA
01/2016
1
alpha-hydroxyglutarate
IBA
07/2014
1
Pharmaceutical Preparations
IBA
07/2014
1
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
07/2014
1
Glutamine (L-Glutamine)
FDA Link
07/2014
1
zaprinast
IBA
07/2014
1
Histones (Histone)
IBA
07/2014
1
Agar
IBA
07/2014
1
Glutamate-Ammonia Ligase (Glutamine Synthetase)
IBA
01/2014
1
resazurin
IBA
01/2014
1
glutamate decarboxylase 1
IBA
01/2014
1
Benzodiazepines
IBA
08/2006
1
Carbidopa (Lodosyn)
FDA Link
Generic
08/2006
1
Diuretics
IBA
08/2006
1
Flumazenil (Romazicon)
FDA Link
Generic
08/2006
1
Calcium
IBA
08/2006
1
Biogenic Amines (Biogenic Amine)
IBA
01/2006
1
Polyamines
IBA
01/2006
1
Peptides (Polypeptides)
IBA
01/2006
1
Amino Acids
FDA Link
01/2006
1
Glutamate Decarboxylase (Decarboxylase, Glutamate)
IBA
07/2005
1
Carrier Proteins (Binding Protein)
IBA
07/2005
1
Oxidoreductases (Dehydrogenase)
IBA
07/2005
1
Amines
IBA
07/2005
1
Neoplasm Antigens (Tumor Antigens)
IBA
03/2004
1
DNA (Deoxyribonucleic Acid)
IBA
03/2004
1
cytoplasmic antiproteinase
IBA
11/2002
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
11/2002
Therapy/Procedure
5
Therapeutics
01/2021 - 01/2016
2
bitter melon extract
11/2019 - 10/2019
2
Immunotherapy
01/2019 - 01/2017
2
Lasers (Laser)
03/2004 - 11/2002
1
Radiotherapy
07/2022
1
Castration
01/2021
1
Prostatectomy (Retropubic Prostatectomy)
01/2021
1
Drug Therapy (Chemotherapy)
01/2019
1
Precision Medicine
01/2019
1
Cytoreduction Surgical Procedures
11/2017